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StructureChionodracine (Cnd) is a 22-residue peptide of the piscidin family expressed in the gills of the Chionodraco
hamatus as protection frombacterial infections. Here,we report the effects of synthetic Cndonboth Psychrobacter
sp. TAD1 and Escherichia coli bacteria, as well as membrane models. We found that Cnd perforates the inner and
outer membranes of Psychrobacter sp. TAD1, making discrete pores that cause the cellular content to leak out.
Membrane disruption studies using intrinsic and extrinsic ﬂuorescence spectroscopy revealed that Cnd behaves
similarly to other piscidins, with comparablemembranepartition coefﬁcients.Membrane accessibility assays and
structural studies using NMR in detergent micelles show that Cnd adopts a canonical topology of antimicrobial
helical peptides, with the hydrophobic face toward the lipid environment and the hydrophilic face toward the
bulk solvent. The analysis of Cnd free energy of binding to vesicles with different lipid contents indicates a
preference for charged phospholipids and a more marked binding to native E. coli extracts. Taken with previous
studies on piscidin-like peptides, we conclude that Cnd ﬁrst adsorbs to the membrane, and then forms pores
together with membrane fragmentation. Since Cnd has only marginal hemolytic activity, it constitutes a good
template for developing new antimicrobial agents.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Antimicrobial peptides (AMPs) represent an ancestral eukaryotic
mechanism of immunity against prokaryotic organisms [1–3]. In partic-
ular, ﬁsh express a large variety of antimicrobial peptides, such as
defensins, cathelicidins, hepcidins and piscidins [4–6]. Fish AMPs such
as piscidin-2 act as anti-infective agents, and display high potency
against human and ﬁsh pathogens [7], while other peptides, such as
epinecidin-1, show anticancer activity against human ﬁbrosarcoma
cells [8].
Among the ﬁsh AMPs, piscidins constitute a rather interesting fami-
ly. They are histidine- and phenylalanine-rich peptides with a broad
spectrum of antimicrobial activity, and are effective against viruses,
fungi and bacteria [7]. Three isoforms of piscidin have been isolated
from the ﬁsh mast cells (i.e., piscidins 1, 2, and 3), differing by one or
two residues [9]. Also, a new type of piscidin (i.e., piscidin 4) comprising
44 residues has been isolated and characterized from hybrid striped
bass [10]. Interestingly, piscidins display in vitro anti-tumor activityelli@unitus.it (F. Porcelli).against various cancer cell lines, such as HL60, HeLa [11], MCF7, and
4T1 [12]. While the activity of piscidins has been attributed to their
ability to form pores and disrupt cell membranes, they also have immu-
nomodulatory properties, suggesting that they may target speciﬁc
receptors [13,14]. Other reports show that piscidins may also inhibit
the biosynthesis of the cell wall, nucleic acids, and proteins, or, alterna-
tively inhibit pathogens' enzymatic activity [5].
We recently discovered a new antimicrobial peptide of the piscidin
family named chionodracine (Cnd), which is produced by Chionodraco
hamatus, an Antarctic teleost iceﬁsh, of the Channichthyidae family
[4]. Cnd protects Chionodraco from infections; speciﬁcally, from the
attack of Psychrobacter sp. TAD1 and TA144, two psychrotolerant and
psychrophilic bacteria strains typical of the Antarctic marine and terres-
trial environments [4]. Cnd is expressed in the gills and head kidney of
the Chionodraco as an 80 amino acid precursor and cleaved into a ma-
ture 22-residue peptide (FFGHLYRGITSVVKHVHGLLSG). We found that
Cnd is active toward both Psychrobacter sp. TAD1 and TA144, but also
shows activity toward Gram-positive Bacillus cereus and Gram-
negative Escherichia coli. The minimum inhibitory concentrations
(MIC) of the Cnd against mesophilic and psychrophilic bacteria have
been previously reported and range between5.00 and 20 μM[4]. Impor-
tantly, Cnd does not show any signiﬁcant hemolytic activity toward
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making it a promising template to develop newmolecules with antimi-
crobial activity. Cnd's primary sequence is remarkably similar to that of
other peptides belonging to the piscidin family, sharing the two N-
terminal phenylalanines, the central glycine, and three histidines
(Fig. 1). Although we have described the gene sequence, localization
as well as the bactericidal activity of Cnd, we had yet to determine its
interactions with prokaryotic cell membranes as well as the molecular
and structural features of this peptide in membrane mimetic
environments.
Here, we report the membranolytic properties and structural char-
acterization of Cnd using transmission electron microscopy (TEM), cell
permeation assays, andNMR spectroscopy.We found that Cnd interacts
with cell membranes, disrupting the inner and outer membranes of
both Psychrobacter sp. TAD1 and E. coli bacteria. In particular, TEM
images reveal that Cnd forms well-deﬁned pores in the bacterial mem-
branes. Moreover, experiments carried out with synthetic membranes
reveal a small but signiﬁcant preference for negatively charged lipid
membranes and a more marked afﬁnity for E. coli bacteria membranes.
The three-dimensional structure of Cnd is very similar to that of the
piscidin-1 peptide, adopting a canonical amphipathic helix, with hydro-
phobic amino acids adsorbed on the membrane surface and the hydro-
philic amino acids pointing toward the bulk solvent. Taken together, the
helical propensity (disorder to order transition), membrane binding as-
says, and TEM images show the formation of discrete pores as well as
membrane fragmentation that enable the cellular content to leak out
and killing the cells.
2. Material and methods
2.1. Peptide synthesis
The Cnd peptide (N95%) FFGHLYRGITSVVKHVHGLLSGwas purchased
from United Biosystems Inc., USA. Peptide concentration was deter-
mined by light absorption at 280 nm before each sample preparation.
2.2. Lipid vesicle preparation
LUVs (Large Unilamellar Vesicles) of the appropriate lipid or lipid
mix suspension were prepared by extrusion with an Avanti Polar
mini-extruder through a polycarbonate membrane with pore sizes of
100 nm. Lipid vesicles were composed of 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC), mixtures of POPC and 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphoglyceol (POPG), or E. coli B extract,
ATCC 11303, comprised of 57.5% PE, 15.1% PG, 9.8% cardiolipin (CA),
and 17.6% unknown (Avanti Polar Lipids Inc.). All the lipid vesicles
were prepared as reported in the following sections.
2.3. Transmission Electron Microscopy (TEM)
Psychrobacter sp. TAD1 Antarctic bacteria were grown aerobically
and cultured at 15 °C for 48 h in Luria–Bertani broth to mid-log phase
(OD 600 of 0.35), centrifuged at 3000 g for 10 min at 25 °C, washed
and resuspended into 10 mM Tris–HCl (pH 7.4), and 150 mM NaCl
(working buffer) to a ﬁnal OD600 of 0.5. Treated cells were incubated
with Cnd antimicrobial peptide (15 μM, PM 2424.83) while controlFig. 1. Primary sequences for Cnd and other piscidin antimicrobial peptides with sequence
homology highlighted.cells were maintained in working buffer, all the groups of cells
were then collected at 0, 10 and 180 min and ﬁxed with 2%
paraformaldehyde + 2.5% glutaraldehyde in cacodylate sucrose buffer
(0.1 M cacodylate, 0.09 M sucrose, 0.01 M CaCl2, 0.01 M MgCl2,
pH 6.9) containing 0.075% ruthenium red and 0.075 M lysine acetate
for 20 min at 4 °C. Samples were washed in cacodylate sucrose
buffer containing 0.075% ruthenium red and then ﬁxed with 2%
paraformaldehyde + 2.5% glutaraldehyde in cacodylate sucrose buffer
containing 0.075% ruthenium red overnight at 4 °C. After washings in
the cacodylate sucrose buffer containing 0.075% ruthenium red, samples
were post-ﬁxed in 1% OsO4 + 0.075% ruthenium red in 0.1 M
cacodylate buffer at pH 7.2 for 1 h at room temperature and then
washed again in the cacodylate sucrose buffer containing 0.075% ruthe-
nium red. Specimens were dehydrated in a graded ethanol series and
embedded in LR White resin (Multilab Supplies, Surrey, England) [15].
The resin was polymerised in tightly capped gelatine capsules for 48 h
at 50 °C. Thin sectionswere cut with Reichert Ultracut and LKB Nova ul-
tramicrotomes using a diamond knife, collected on copper grids, stained
with uranyl acetate and lead citrate, and observedwith a JEOL 1200 EX II
electron microscope at 100 kV. Micrographs were acquired by the
Olympus SIS VELETA CCD camera equipped the iTEM software. TEM im-
ages (at the same magniﬁcation) were analysed to determine the per-
centage of damaged bacteria (bacteria with destroyed membranes)
both in controls and treated cells, by counting a total number of
50,000 cells. All the numerical results are presented in the text as
mean ± SD. Homogeneity of variances was tested before data process-
ing. To detail the source of variation attributed to treatment and time
factors, two-way ANOVA was applied, followed by Bonferroni's test.
Data were analysed using the GraphPad Prism 3.0 software statistical
package. The level for accepted statistical signiﬁcance was P b 0.01.
2.4. Steady-state ﬂuorescence experiments
2.4.1. Partition studies
A Perkin Elmer LS55 steady-state ﬂuorescence spectrometer was
used for steady-state ﬂuorescence measurements. The experiments
were carried out at 25 °C in a thermostated cell holder equipped with
magnetic stirrer. In order to correct for polarization effects and reduce
direct contributions from the vesicles, light scattering measurements
were carried out with a cross-oriented conﬁguration of polarizers
(Polem = 0° and Polexc = 90°) [16]. The partition of Cnd with lipid vesi-
cles was quantiﬁed by titrating the peptide samples in 20 mM phos-
phate buffer at pH 7.4 containing EDTA 0.8 mM and NaCl 150 mM
with increasing amounts of vesicle stock solutions; the lipid/peptide
ratio ranged from 50 to 500. These binding assays were repeated with
LUVs of different compositions: 100% POPC, 70%/30% POPC/POPG, and
E. coli B extract. The lipid titrations were monitored following the in-
crease of Tyr-6 ﬂuorescence at λem = 320 nm upon excitation at
λexc = 274. The background signals of both buffer and lipid vesicles
were subtracted from each spectrum. The partition constant Kx, was de-
ﬁned according to Wimley and White [17,18]:
Kx ¼
P½ bil= L½ 
P½ water= W½ 
where [P]bil and [P]water are the bulk molar concentration of peptide in
the bilayer and in the water, and [L] and [W] are the molar concentra-
tions of lipid and water, respectively. The partition constants were
measured by titrating a 1 μM solution of Cnd with increasing amounts
of lipid vesicles of varying compositions, then calculating the fraction
of the peptide, fp, partitioned into the lipid vesicles. Considering that
[P]tot = [P]water + [P]bil [19,20], the expression for fp is:
f x ¼
Kx L½ 
W½  þ Kx L½ 
:
1287C. Olivieri et al. / Biochimica et Biophysica Acta 1848 (2015) 1285–1293The values of Kx were determined by the plot of fp vs [L] using the
GraphPad Prism 6 software package (GraphPad Software Inc.). Experi-
mental data were ﬁtted using equation [19]:
F
Fo
¼ 1þ Fmax−1ð Þ f p
where F is the ﬂuorescence intensity, Fo and Fmax are the ﬂuorescence
intensities before lipid vesicle addition and at saturation, respectively.
In order to avoid the non-ideal behavior occurring at higher concentra-
tions [18,21], the molar partition coefﬁcients were evaluated at a low
peptide concentration (~1 μM).
2.4.2. Outer membrane disruption assay
For cell permeabilization studies, we used ANS (1-aminonaphtalene-
8-sulfonic acid) uptake assays [22] with E. coli BL21(DE3) and
Psychrobacter sp. TDA1 bacteria. Bacterial cells were cultured in LBmedi-
um. Cells from themid-log phasewere centrifuged,washed, and then re-
suspended in PBS buffer to achieve an OD600 of ~1.2. Increasing amounts
of peptide (ranging from1.0 to 15.0 μM)were added to 1.0mLof cell sus-
pension in the presence of 5.0 μMof ANS. The spectra were recorded be-
tween 400 and 600 nm with an excitation wavelength of 360 nm and
excitation/emission band-passes of 5.0 nm. The disruption of the outer
membrane was quantiﬁed by the increase in ﬂuorescence intensity and
the blue shift of the spectra.
2.4.3. Calcein leakage studies
The kinetics of calcein releasewere followed bymonitoring theﬂuo-
rescence increase upon peptide binding to vesicles at different lipid
compositions. LUVs charged with 50 mM calcein were prepared by an
extrusion process. Brieﬂy, the appropriate amount of lipids was dis-
solved in chloroform in a small round bottom ﬂask and the solvent
was gently removed in a rotary evaporator. The remaining solvent
was removed under vacuum overnight at room temperature. The
dried lipid ﬁlms were hydrated with MOPS buffer at pH 7.5 containing
70 mM NaCl, E0.8 mM DTA, and 50 mM calcein. The lipid suspensions
were vortexed at room temperature and subjected to 5 freezing and
thawing cycles. After freezing, the sample was heated to 50 °C and the
mixture subjected to extrusion cycles using an Avanti polar mini-
extruder containing two stacked 100 nmpolycarbonate ﬁlters. To sepa-
rate the non-encapsulated calcein in the external medium, the mixture
was passed through a Sephadex-G50 column. Columns containing the
calcein-loaded vesicles were centrifuged for 3 min at 1000 rpm. The
lipid concentration was measured via the static light scattering at 90°
of the lipid suspension at 550 nm and compared with a calibration
curve [23]. The Bartlett method was used to determine the total phos-
pholipid concentration. Fluorescence studies were carried out at 25 °C
with an excitationwavelength of 490 nm, producing an emissionwave-
length of 520 nm. The excitation and emission band-passes were
2.5 nm. LUVs charged with 50 mM calcein showed very little ﬂuores-
cence quantum yield due to calcein self-quenching. The increase in ob-
served ﬂuorescence was due to the vesicle leakage caused by peptide
addition. Before peptide titration (from 0.1 to 1.0 μM), the ﬂuorescence
baseline was monitored for 5 min and no deviations were observed.
After peptide addition, the ﬂuorescence was monitored up to 2000 s.
To obtain the maximal leakage of the vesicles and normalize ﬂuores-
cence intensities, we added ~5 μL of 0.1% solution of Triton X to each
sample. Before each measurement, we performed light scattering
experiments between 540 and 560 nm to assess the integrity of the ves-
icles [23]. Fluorescence traces were ﬁtted with a double exponential
equation [23]
Ft ¼ Feq−a1e−k1t−a2e−k2t
where Ft and Feq are the ﬂuorescence at time t and at t→∞,respectively,
the constants a1 and a2 represent the fractions of the two kineticcomponents and k1 and k2 are the respective constants expressed in
s−1. The percentage of calcein releasewas calculated using the formula:
Dyerelease %ð Þ ¼ F−F0
Ft−F0
where F is the ﬂuorescence upon addition of peptide, F0 is the initial
ﬂuorescence before the addition of peptide and Ft is the ﬂuorescence
upon addition of Triton-X.
2.4.4. Iodide quenching experiments
Quenching of the tyrosine ﬂuorescence both in the presence and
absence of lipid vesicles was measured by addition of increasing ali-
quots of potassium iodide [24]. The excitation wavelength was set to
274 nm and ﬂorescence spectra were recorded between 295 and
360 nm. Fluorescence spectrawere corrected for dilution and for the ab-
sorption of ﬂuorophores and quenchers. The data were ﬁtted according
to the Stern–Volmer equation:
Fo
F
¼ 1þ KSV Q½ 
where Fo and F are the ﬂuorescence in the absence and presence of the
quencherQ, respectively, and KSV is the Stern–Volmer constant account-
ing for the collisional quenching process [25].
2.5. NMR sample preparation and spectroscopy
The lyophilized peptide was dissolved in an aqueous solution (5%
2H2O, 95%H2O) containing 300mMperdeuteratedDPC (Cambridge Iso-
tope Laboratories) and 20 mM phosphate buffer at pH ~6.5 to a ﬁnal
concentration of ~1.5 mM. All of the NMR experiments were acquired
at 300 K on a Varian Inova 900 MHz spectrometer. The 2D [1H, 1H]
total correlation spectroscopy (TOCSY) [26] (50 and 70 ms mixing
time) and 2D [1H, 1H] NOESY [27] (70–300 ms mixing time) experi-
ments were run in the phase-sensitive mode using time-proportional
phase incrementation (TPPI) for quadrature detection in the indirect di-
mension. All of the pulse sequences utilized a WATERGATE pulse
scheme [28] for solvent suppression. The experiments were acquired
with 256 and 1024 complex data points in the t1 and t2 dimensions, re-
spectively, with 64 scans per increment. The 90° pulse width was
30 kHz, and recycle delay was set to 1 s. A DIPSI-2 pulse sequence [29]
was used for isotropic mixing in the 2D TOCSY experiments. The spec-
tral widths were 5400 Hz t1 and 7200 Hz t2 dimensions. The 2D data
were zero-ﬁlled to 8192 points in t1 and to 4096 points in t2 and then
processed with a sine-bell squared window function shifted between
60° and 90° before Fourier transformation. A polynomial function was
used for baseline correction in the direct frequency dimension. The
NMR data were processed using NMRPipe [30] and analyzed with
SPARKY [31] software packages. Proton dimension was referenced to
thewater line at 4.7 ppm. The spectra were assigned using the standard
assignment approach described by Wuthrich [32]. [1H,13C] HSQC and
HMBC spectra were acquired on a Bruker 900 MHz spectrometer at
30 °C. All the 13C experiments were carried out at natural abundance.
Analysis of the natural abundance of 13C edited HSQC and HMBC has
been used to resolve amino acid spin systemassignments aswell as pro-
vide 13Cα and 13Cβ chemical shifts. A table with all of the 1H and 13C
chemical shift resonances is provided in the supporting information.
2.6. Structure calculations from NMR data
NOE cross-peaks from the 150 and 300 ms mixing time [1H, 1H]-
NOESY experiments were integrated and used for the structure calcula-
tions. The NOE volumes were calibrated using the average NOE volume
from resolved aromatic vicinal protons of Y6 and classiﬁed as strong,
medium, and weak, corresponding to distance restraints of 1.8–2.9,
1.8–4.5, and 1.8–5.0 Å, respectively. TALOS+ software [33] was used
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then implemented in the structure calculations. The NMR conformers
were calculated starting from an extended conformation of Cnd and
minimized using a hybrid simulated annealing (SA) energy minimiza-
tion protocol available in XPLOR-NIH [34]. A total of 100 conformers
were generated using random seeds at an initial temperature of
5000 K with 6000 high temperature steps, 3000 cooling steps, and a
step size of 5 fs. The ﬁnal target function included a total of 240 NOEs
(75 intra-residue and 165 inter-residue distances). The ﬁnal stage of re-
ﬁnement of the structural ensemblewas carried out starting at an initial
temperature of 500 K and using 30,000 cooling steps with a 1 fs step
size. The 70 reﬁned structures had no NOE violations greater than
0.5 Å, no bond violations greater than 0.05 Å, and no bond angle viola-
tions greater than 4°. The 40 lowest energy conformers were then se-
lected for further analysis. The analysis of Ramachandran angles for
the 40 lowest energy structures was carried out using Molprobity [35].Fig. 2. TEMmicrographs of ultrathin sections from Psychrobacter sp. TAD1. (A) General view of c
cells surrounded by twomembranous structures: the innermembrane and the outermembrane
showingmembrane damage after 10 min of treatment (arrows). (E) Higher magniﬁcation of da
(F) Dividing cellswith leakage of cellular contents after 10min of treatment. (G) A detail of fragm
brane; OM: outer membrane. Scale bar: 2 μm in (A); 250 nm in (B); 250 nm in (C); 2 μm in (DFor the ﬁnal conformers, the occurrence of the ϕ and ψ angles for all of
the residues in the Ramachandran plots was 83.6% in the most favored
region, 11.1% in the allowed, 1.6% in the generously allowed, and 3.7%
in disallowed regions. The residues located in the N- and C-termini,
which had fewer structural restraints, account for those found in the
disallowed regions of the Ramachandran plots.
3. Results
3.1. Effects of Cnd on the inner and outer membranes of Psychrobacter sp.
TAD1 bacteria using transmission electron microscopy (TEM)
Examination of the Psychrobacter sp. TAD1 by TEM (Fig. 2A) revealed
that the bacterium is bounded by two membranous structures. These
two membranes, the inner membrane (IM) and the outer membrane
(OM), are separated by a gel-like layer known as the periplasmells showing the OMVs interspersed among bacteria (arrow heads). (B)Magniﬁed view of
. (C) Image showing theOMVsprotruding from thebacterial outermembrane. (D) Bacteria
maged bacteria showing discrete pores (arrows) together withmembrane fragmentation.
ents of destroyed cellularmembranes (arrows) after 10min of treatment. IM: innermem-
); 2 μm in (E); 500 nm in (F); 1 μm in (G).
Fig. 3. Percentage of Psychrobacter sp. TAD1 damaged bacteria. TEM images were analyzed
to determine the percentage of mortality both in controls and treated cells (at the same
magniﬁcation), by counting a total number of 50,000 cells. Data were collected at different
times (0, 10 and 180min in) and only cells with completely fragmentedmembraneswere
considered. Numerical results are presented asmean± SD. The level for accepted statisti-
cal signiﬁcance was P b 0.01. Signiﬁcantly different (P b 0.01) from: (a) peptide 0 min,
(b) control 0 min, (c) control 10 min, and (d) control 180 min.
Fig. 5. Binding isotherms for Cnd upon addition of increasing amount of lipid vesicles. The
concentration of peptide was 10.0 μM.
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membrane vesicles (OMVs) of Gram-negative bacteria, were found in
the extracellular matter, mainly interspersed among cells. A process of
bulging out and pinching off of a portion of the bacterial OM, which
plays a dynamic role in the formation of OMVs, was noticed in many
cells (Fig. 2A; C). The formation of OMVs is a common feature of cold-
adapted bacteria that utilize these extracellular vesicles for sensing nu-
trients [36].
Compared to control, treatment of Psychrobacter sp. TAD1 bacteria
with the Cnd peptide (10–80 min) induced a signiﬁcant increase
(P b 0.01) of the number of cells with membrane damage (Fig. 3).
After 10 min of treatment Cnd perforated both OMs and IMs, with
the consequent loss of intracellular components (Figs. 2D and E). Inter-
estingly, this process is localized in well-deﬁned areas, suggesting the
formation of well-deﬁned pores (Fig. 2E). After 180 min of treatment
we observed no further increase of damaged bacteria (Fig. 3). Cnd also
damaged the cell membranes of dividing cells, with leakage of cellular
contents and breakup of the basic cellular structure (Fig. 2F). In the ex-
tracellular matter were observed fragments of destroyed cellular mem-
branes, whose contents were lacking (Fig. 2G). The morphology of the
cellular damage and the time course of the process suggest that Cnd
might aggregate on the cell surface, formingwell-deﬁned pores togeth-
er with membrane fragmentation. Discrete pores have been observed
for the antimicrobial peptide piscidin-1 [5].
3.2. Outer membrane permeability assay
To compare the ability of Cnd to damage the integrity of the outer
membrane of Psychrobacter sp. TDA1 and E. coli bacteria, we used the
ANS (1-aminonaphtalene-8-sulfonic acid) ﬂuorescence assay [22]. Be-
cause of its hydrophobic nature, ANS is not able to pass the cell wall of
either Psychrobacter sp. TAD1 or E. coli, giving rise to aweakﬂuorescence
signal caused by the high polarity ofwater. Upon titration of the bacteriaFig. 4. Permeabilization of E. coli (A) and TAD1 (B) outermembrane by Cnd. Fluorescence of AN
through 15 μM. The cell density measured at OD600 was 1.2.cells with Cnd, ANS penetrates the cell membranes, causing a drastic in-
crease of its ﬂuorescence accompanied by a blue shift of the band
(Fig. 4). This dose-dependent effect is notable at concentrations as low
as 1 μM for both Psychrobacter sp. and E. coli bacteria, conﬁrming our
previous data from the antibacterial activity assays [4].
3.3. Membrane partition of the chionodracine peptide
To quantify the interaction of Cnd with membrane mimetic systems
and assess the effects of lipid charges, we measured the ﬂuorescence
emission of Tyr-6 of Cnd upon partitioningwithin membranes of differ-
ent compositions. Fig. 5 shows the binding isotherms for Cnd upon ad-
dition of increasing amount of lipid vesicles.
The mole fraction partition coefﬁcients Kx obtained from the curves
ranging from 3 × 104 to 2 × 105 are reported in Table 1. The calculated
Gibbs free energies of the water/bilayer partition are −25.6 kJ/mol
for pure POPC, −26.5 kJ/mol for the POPC/POPG mixture, and
−29.9 kJ/mol for the E. coli lipid extract. From these data, it is possi-
ble to see a small but signiﬁcant increase of Kx value using the POPC:
POPG mixture. The higher propensity to partition in native E. coli
lipid extract can be explained by both charge effects and other con-
stituents such as phosphatidylethanolamine (67% wt/wt) and
cardiolipin that may anchor the peptide to themembrane. Analogous
results have been reported by Vogel and co-workers for indolicin and
tritrpticin in interaction with model and natural membranes [37].
3.4. Calcein release studies
Membrane permeabilization by Cndwas also studied by monitoring
the increase of calcein ﬂuorescence upon addition of peptide. As calcein
has excitation and emission wavelengths of 490 nm and 520 nm, re-
spectively, its leakage from POPC, POPC/POPG (70/30 wt/wt) and
E. coli extract LUVs was measured as a function of time at different pep-
tide concentrations ranging from 0.1 to 1.0 μM.When a high concentra-
tion of calcein is present in the LUVs, the ﬂuorescence is self-quenched.
After addition of Cnd to the calcein-loaded vesicles, a gradual release ofS equilibratedwith cells and in the presence of increasing amount of Cnd peptide from 1.0
Table 2
Relative leakage capabilities of Cnd, at different peptide/lipid ratios, in the presence of
100% POPC, 70/30 POPC/POPG and 100% total E. coli lipid extract LUVs.
Peptide/lipid
(molar ratio)
Relative leakage
PC LUVs
Relative leakage
POPC/POPG
(70/30) LUVs
Relative leakage E. coli
total extract LUVs
1/25 63% 100% 18%
1/50 26% 90% 13%
1/100 11% 60% 9%
Table 1
Partition parameters for Cnd in the presence of differentmixtures of POPC/POPGand E. coli
total lipid extract.
Peptide
concentration
Lipid composition Kx ΔG (kJ/mol)
1.0 μM POPC (3.43 ± 0.26) × 104 −25.9
POPC/POPG (70/30 w/w) (4.91 ± 0.29) × 104 −26.7
Total E. coli extract (1.83 ± 0.08) × 105 −30.0
Fig. 7. Stern–Volmer plots for the quenching of Tyrosine 6 of Cnd by KI in aqueous buffer
and in the presence of POPC, POPC/POPG (70/30) and E. coli total extract LUVs.
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conﬁrm that calcein release was due to vesicle/peptide interaction and
not to vesicle rupture, the integrity of the lipid vesicles was determined
by right angle light scattering. In Table 2, the relative leakage capabilities
of Cndwith different liposome vesicles are reported as function of lipid/
peptide ratio. We employed POPC vesicles, negatively charged vesicles
containing POPC/POPG (70/30 w/w) to simulate bacterial cell mem-
branes, and E. coli extract vesicles. The relative percentage of leakage
shows that the dose-response of Cnd-induced calcein leakage is more
effective in the presence of negatively charged membranes, especially
at a low peptide/lipid ratio. The minor leakage capability observed for
E. coli lipid extract was also reported by Vogel et al. [37] for tryptophan
rich cathelicidin antimicrobial peptides; this was attributed to the com-
plexity of the E. coli extract making vesicles less prone to disruption.
We also examined the kinetics of leakage using amethod developed
by Tatulian and co-workers [23]. Fig. 6 shows the fractional release of
calcein from a solution containing 25 μM of POPC/POPG vesicles as anFig. 6. Kinetics of calcein efﬂux from LUVs after addition of different amount of Cnd from 0.1
A) Kinetics curves for POPC LUVs (25.0 μM) at different peptide concentrations; B) kinetics cu
and D) kinetics curves for POPC/POPG (70/30) LUVs (50.0 μM). Note the difference in time scaexample of peptide-induced calcein release. Upon addition of the pep-
tide, a gradual increase ofﬂuorescence due to calcein release is observed
until ﬂuorescence reaches the equilibrium, Feq.
The values of the kinetic parameters accounting for the fast and the
slow components of the process are reported in Table S1. The kinetic
constants depend on themembrane charge and peptide concentrations
and range from 0.2–2.0 min and 7–59 min for the fast and the slow
components.
3.5. Fluorescence quenching experiments
The degree of peptide exposure to the bulk solvent was assessed
through Tyr-6 ﬂuorescence quenching experiments using iodide ions
as a quencher [25]. Fig. 7 shows the Stern–Volmer plots for iodide
quenching of Cnd in the absence and presence of POPC, POPC/POPG
and E. coli extract.
The data are corrected for both dilution and absorption of
ﬂuorophores. The iodide quenching curves follow a linear correlation
with the KI concentration, indicative of collisional quenching. The KSV
values, obtained from the slopes of the curves and accounting for the
dynamic quenching, are reported in Table 3.0 μM through 1.0 μM. The curves are the experimental data normalized by Triton X-100.
rves for POPC LUVs (50.0 μM); C) kinetics curves for POPC/POPG (70/30) LUVs (25.0 μM)
le for different panels.
Table 3
KI quenching. Stern–Volmer quenching constant (KSV) and percentage of iodide
quenching for Cnd in the presence of different lipid vesicles. The peptide/lipid molar ratio
was 1:100 in all cases.
KSV (M−1) 1/KSV (M) Percent of quenching
Buffer 10.4 ± 0.2 0.096 100
POPC (LUVs) 2.9 ± 0.1 0.340 28.4
POPC–POPG (70:30 LUVs) 2.5 ± 0.1 0.408 23.6
E. coli (LUVs) 1.6 ± 0.2 0.625 15.4
Fig. 8.NMR structuralmodels of Cnd. A)Histogram of the backbone RMSD versus residues
for the ﬁnal 40 Cnd conformers, superimposing heavy atoms for residues 2–20;
B) conformational ensemble showing the convergence of the structures for heavy atoms
of the backbone; C) representative structure of Cnd showing the two faces of the
amphipathic helix. The hydrophilic residues are represented in orange and the hydropho-
bic residues in green.
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(KSV≈ 10 M−1) than in the presence of vesicles (KSV≈ 3 M−1), with
the slopes determined in the presence of vesicles ~3–6 fold smaller
than in buffer only. This implies that Tyr-6 has a higher accessibility to
solvent in the absence of lipid membranes, and suggests that Tyr-6 par-
titions at the interfacial region of the lipid bilayer. As for the partition
constant, the quenching experiments show that the peptide interacts
more strongly with charged lipids and with native E. coli membranes
than with POPC.
3.6. NMR studies of chionodracine in micelles
For the structural studies, Cnd was reconstituted in DPC micelles
[38–40]. Sequence speciﬁc resonance assignments were obtained by a
combination of 2D [1H–1H]-TOCSY and [1H–1H]-NOESY spectra. From
these spectra, we assigned most of the resonances and NOE connectivi-
ties. Due to slow tumbling of the peptide in micelles, we were not able
to measure the J coupling constants [38–41]. The complete resonance
assignment is given in Table S2. In the TOCSY experiment, we were
able to assign most of the ﬁngerprint region containing Hα–HN cross-
peaks. However, only a few spin systems show correlations between
the amide and the side chains due to the inefﬁcient relay of magnetiza-
tion. The peptide spin system assignment was achieved following the
NOESY-walk method reported by Wuthrich [32]. From the analysis of
the NOESY spectra at 300 ms, a total of 240 NOEs (75 intra-residue
and 165 inter-residue) were assigned. Fig. S3 shows the summary of
NMR data and NOEs connectivities obtained for the ﬁngerprint region
Hα–HN, the backbone NOE patterns, and the chemical shift index
for Hα [42]. We assigned several dNN (i,i + 1) and dαN (i,i + 1)
along the peptide backbone, aswell as dαN (i,i+ 2). Connectivities diag-
nostic of an α-helical conformation, such as dαN (i,i + 3), dαN (i,i + 4),
dNN (i,i + 3) and dαβ (i,i + 3), were detected along the entire peptide
backbone, especially in the region between residues 5 and 20. From
the analysis of the natural abundance 13C-edited HSQC, we were able
to resolve the amino acid spin system and assign Cα and Cβ for the
different residues. NMR chemical shifts are strongly related to the sec-
ondary structure of proteins and peptides and can be used to calculate
the structures [42,43]. To obtain Cnd peptide backbone torsion angles,
we input the chemical shifts into TALOS+ [33]. Fig. S4 C reports the
RCI-S2, Random Coil Index derived order parameter S2 [43], predicting
protein ﬂexibility, and the ANN-predicted secondary structure calculat-
ed from backbone chemical shifts of Hα, HN, Cα and Cβ using TALOS+
[33]. According to this method, RCI-S2 values less than 0.5 indicate dy-
namic residues. In Fig. S4, the bar length is proportional to the probabil-
ity of the residues to be in either a helix (negative values) or beta-sheet
(positive values) conformation. For the Cnd peptide, the average order
parameter for residues 5–20 is ~0.8, except for the C-terminal region,
which is predicted to be disordered. The conformers obtained from
the XPLOR-NIH calculations [34] conﬁrmed this prediction. Fig. 8 dis-
plays the superposition of the 40 lowest energy conformers obtained
from the structure calculations as well as the average structure. As
shown in Fig. 8, the well-deﬁned ensemble is arranged in an α-helical
conformation between residues 5 through 20, featuring a classical am-
phipathic α-helix.
The superposition of backbone atoms between residues H4 through
L20 gives a RMSD of 0.30± 0.17 Å, and a RMSD of 0.92± 0.28 Å for theheavy atoms. From the analysis of the amphipathic helix, there is
evidence that hydrophobic residues are on the face of the peptide that
is likely closest to the lipid bilayer. The statistics for the 40 best NMR
structures of Cnd in DPC micelles are reported in Table S3.
4. Discussion and conclusion
Interest in studying AMPs has grown signiﬁcantly in recent years
due to the fact that increasing bacterial resistance to conventional anti-
biotics is becoming a global emergency [44,45]. The majority of AMPs
share the ability to kill a broad spectrum of prokaryotic cells by
interactingwith anddisrupting bacterial cellmembranes [46–49]. In ad-
dition, several AMPs are involved in modulating immune and inﬂam-
matory responses [50,51]. AMPs' broad spectrum of activity, as well as
the obstacles they present to the development of resistance, makes
them an important candidate for a valid alternative to conventional an-
tibiotics [52]. In fact, some AMPs are already used, in drug formulation,
to topically treat infections [45]. Recent studies, reviewed by Hancock,
show that AMPs also have immunomodulatory properties [51].
Generally, AMPs such as piscidins are cationic, small (15–45 resi-
dues), and amphipathic, with about 50% of their residues hydrophobic
to facilitate the interaction with cell membranes [53,54]. Since the ﬁrst
antimicrobial peptide, nisin was isolated in 1947, more than 1800
AMPs have been identiﬁed, some natively expressed and others synthe-
sized and tested against different microorganisms [55]. Unfortunately, a
uniﬁed mechanism of action of AMPs has not yet been found. The only
way to understand their biological function is to combine functional as-
says with detailed structural studies [38–40,56,57].
Peptides derived from ﬁsh are attracting growing attention, as they
are active at high salt concentrations and a wide range of temperatures,
making them ideal candidates for antimicrobial drugs. Pardaxin
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bial peptide to be discovered and characterized [38,58]. Thereafter,
many peptides showing a broad-spectrum of antimicrobial activity
were isolated from ﬁsh, such as misgurin from the loach Misgurnus
anguillicaudatus [59], pleurocidin from winter ﬂounder (Pleuronectes
americanus) [60], and piscidins from hybrid striped bass (Morone
chrysops female andMorone saxatilismale) [9].
The TEM images show the formation of distinct pores (35–50 nm in
diameter), highly localized at possible points of peptide aggregation.
This mode of permeabilization supports the macroscopic current and
single-channel measurements carried out by Campagna and co-
workers on piscidin-1 [5], supporting the formation of discrete pores.
Moreover the presence of completely fragmented membranes suggests
a carpet-like mechanism of action for Cnd. However Cotten and co-
workers emphasize for piscidins 1 and 3 that is difﬁcult to discern be-
tween these two mechanism suggesting the carpe model as an
extension of pore mechanism [61]. The afﬁnity for synthetic bilayers,
quantiﬁed via the intrinsic ﬂuorescence quantum yield of the native
Tyr 6 of Cnd, shows that the peptide has a piscidin-like behavior with
the cationic residues preferentially targeting negative charged lipid
membranes. As with the other piscidins, Cnd undergoes a disorder-to-
order transition into a well-deﬁned amphipathic α-helical conforma-
tion. The amphipathic α-helix motif is a relevant and well-known
membrane-binding motif in which both hydrophilic and hydrophobic
sites are involved in membrane binding. For instance, an amphipathic
helix form from residue 2 through 22 has also been found for the 22
residue analog peptide piscidin 1 in SDS micelles [62]. The presence of
an amphipathic helix for the analogues piscidin 1 and piscidin 3
has been conﬁrmed by ssNMR studies in lipid bilayer [61,63,64]. Using
ssNMR spectroscopy and MD simulation, Cotten and co-workers
[61] showed that piscidin 1 and piscidin 3 insert and rotate in the
bilayer; furthermore, due to the presence of the aromatic residues at
the N-terminus, it is more deeply inserted in the bilayer than the C-
terminus. For Cnd, NMR derived structures (Fig. 8) indicated that Cnd
interacts with the lipid membrane so that the non-polar face is in con-
tact with the hydrophobic portion of the membrane and the polar resi-
dues are oriented toward the solvent [65]. This evidence is also
conﬁrmed by the Tyr-6 quenching studies. As reported in Table 3, Tyr
6 is much less accessible to the solvent upon bindingwith lipid vesicles,
and the Stern–Volmer constant is 3–6 fold smaller, depending on the
vesicles, than in buffer. The decrease in accessibility of the ﬂuorophore
to the quencher can be explained by the fact that, upon binding, the
N-terminus is deeply inserted into the lipid bilayer due to the presence
of the two phenylalanine residues in positions 1 and 2. Moreover, the
presence of anionic lipids lowers the Gibbs partition energy by about
4 kJ/mol moving from the zwitterionic POPC to the anionic mixture
(POPC/POPG 70:30). We speculate that following binding to the mem-
brane surface, there is a perturbation of the lipidmembrane and the for-
mation of pores and membrane fragmentation that concur to the
leakage of the cell content. To this extent, leakagemeasurements reveal
the ability of Cnd to induce calcein release from lipid vesicles in a dose-
dependent manner, based on both peptide-to-lipid ratio as well as the
type of lipids used (Fig. 4). The efﬂux rates increase in the presence of
a higher peptide/lipid ratio and in the presence of anionic lipids, likely
as a consequence of better binding, as conﬁrmed by higher values of
Kx. At low peptide to lipid ratios the induced leakage is low, while
upon increasing this ratio the leakage also drastically increases [24].
In conclusion, the combination of TEM, ﬂuorescence data, solution
NMR spectroscopy, and lipid binding assays of Cnd support a mecha-
nism of action in which the mature peptide is essentially unstructured
and adopts a canonical α-helical structure upon interaction with lipid
membranes,with a preference toward charged lipids and E. coli extracts.
The TEM images and the NMR data suggest that the initial adsorption of
the peptide onmembranes is followed by the recruiting of othermono-
mers, forming well-deﬁned pores that perforate both inner and outer
membranes. The latter mechanism occurs together with an extensivemembrane fragmentation that concurs to killing bacterial cells. Given
the weak hemolytic activity of Cnd, these data suggest that this peptide
could constitute a great starting point for the development of more spe-
ciﬁc and potent antimicrobial agents.
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